Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Saved in:

Bibliographic Details
Main Authors:	Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina, Elena Elez, Javier Rodriguez, Ian Chau, Maria Di Bartolomeo, Hisato Kawakami, Fumitaka Suto, Makito Koga, Koichiro Inaki, Yusuke Kuwahara, Issey Takehara, Daniel Barrios, Kojiro Kobayashi, Axel Grothey, Takayuki Yoshino
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-01-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-025-56170-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
by: Salvatore Siena, et al.
Published: (2024-11-01)

The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
by: Anna-Maria Lazaratos, et al.
Published: (2024-12-01)

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
by: Satomi Watanabe, et al.
Published: (2019-03-01)

PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
by: Abul Azad, et al.
Published: (2025-01-01)

Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan
by: Ünal Metin Tokat, et al.
Published: (2025-01-01)

‘Her Room Was Her World’: Nellie Sloggett and North Cornish Folklore
by: Simon Young
Published: (2017-12-01)

Her mistletoe miracle
by: FOx Roz Denny
Published: (2008)

PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
by: Eduardo Terán, et al.
Published: (2024-09-01)

How Odynerus Suspends Her Egg
by: Carl G. Hartman
Published: (1944-01-01)

PROTAGORAS: HER ŞEYİN ÖLÇÜSÜ İNSAN
by: Lokman Çilingir
Published: (2022-12-01)

Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
by: Femke A. I. Ehlers, et al.
Published: (2025-01-01)

The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status
by: Sanaa Gamrani, et al.
Published: (2023-01-01)

International Conference “Mina Loy and her Networks”
by: Elise Ottavino
Published: (2023-11-01)

Comparison between Real-Time Quantitative PCR Detection of HER2 mRNA Copy Number in Peripheral Blood and ELISA of Serum HER2 Protein for Determining HER2 Status in Breast Cancer Patients
by: Maria Savino, et al.
Published: (2009-01-01)

Catherine of Siena's wisdom on discernment and her reception of scripture
by: Diana L. Villegas
Published: (2013-06-01)

Emily Dickinson’s Line Breaks in Her Envelope Poems
by: Antoine Cazé
Published: (2021-07-01)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer
by: Miaomiao Jia, et al.
Published: (2024-01-01)

Prophet of Destiny /
by: White,Ellen G.
Published: (1972)

Optimum technique of carotid artery reconstruction in her atherosclerotic lesion
by: V. V. Akhmetov, et al.
Published: (2020-12-01)

"Not At Home in Her Own Skin": Jamaica Kincaid, History and Selfhood
by: Claudia Marquis
Published: (2007-05-01)

A Panel of Three MicroRNA Signatures as a Potential Biomarker for CRC Screening Based on Stages and Functional Prediction Using Bioinformatic Analysis
by: Syarah Syamimi Mohamed, et al.
Published: (2023-08-01)

Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study
by: Fei Wang, et al.
Published: (2025-01-01)

The love for the poor neighbour: in memory of her (Matthew 26:6-13)
by: A. G. van Aarde
Published: (2016-06-01)

Klasifikasi Mahasiswa HER Berbasis Algoritma SVM dan Decision Tree
by: Jajang Jaya Purnama, et al.
Published: (2020-12-01)

Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma
by: Martina Napolitano, et al.
Published: (2025-01-01)

Émilie Du Châtelet’s Metaphysics in Light of her Concept of ‘a Being’
by: Clara Carus
Published: (2024-07-01)

She had been healthy a when he married her
by: Emmanuelle Roussel
Published: (1999-12-01)

Eudora Welty: Sensing the Particular, Revealing the Universal in Her Southern World
by: Pearl McHaney
Published: (2012-01-01)

Analýza světů digitálních her: prostorová sémiotika a její recepce
by: Jakub Škrdla
Published: (2025-01-01)

HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction
by: Robin Chung, et al.
Published: (2025-02-01)

Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
by: Claire Corcoran, et al.
Published: (2025-01-01)

Was Sor Juana a Sphinx? Monstrosity and the Poetics of Dedication in Her Transoceanic Enigmas
by: Víctor Sierra Matute

Role of Fcγ receptors in HER2-targeted breast cancer therapy
by: Hope S Rugo, et al.
Published: (2022-01-01)

Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer
by: Solmaz AghaAmiri, et al.
Published: (2021-01-01)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
by: Agnieszka Halon, et al.
Published: (2012-01-01)

Maintenance Therapy with Trastuzumab in Her2 Positive Metastatic Parotid Ductal Adenocarcinoma
by: Muhammad Shahid Iqbal, et al.
Published: (2014-01-01)

Pregnancy and Lifestyle: Short- and Long-Term Effects on Mother's and Her Children's Health
by: Riitta Luoto, et al.
Published: (2013-01-01)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
by: Maria Antonietta Lucci, et al.
Published: (2010-01-01)

Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma
by: Roberto de Moraes Cordts Filho, et al.
Published: (2016-01-01)

About Marie Skłodowska-Curie on the occasion of her 150th anniversary of the birth
by: Alicja Rafalska-Łasocha
Published: (2018-12-01)